Literature DB >> 3512771

Ethanol does not modify opiate-mediated inhibition of striatal adenylate cyclase.

P L Hoffman, B Tabakoff.   

Abstract

Ethanol increases the activity of "basal," guanine nucleotide- and dopamine-stimulated adenylate cyclase in mouse striatum. In contrast, ethanol, in vitro, did not modify the inhibition of striatal adenylate cyclase activity by opiates (morphine or [D-Ala2,D-Leu5] enkephalin). Following chronic in vivo ethanol treatment of mice, there was also no change in the character of opiate inhibition of striatal adenylate cyclase activity. Since ethanol, in vitro, does decrease striatal opiate receptor binding, the results suggest that the changes in affinity detected by ligand binding studies are not relevant for receptor-coupled adenylate cyclase activity, or that opiate receptor binding and opiate regulation of adenylate cyclase can be modulated independently. The selective effects of ethanol on systems that modulate adenylate cyclase activity may produce imbalances in neuronal function during in vivo ethanol exposure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512771     DOI: 10.1111/j.1471-4159.1986.tb13044.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Cultured lymphocytes from alcoholic subjects have altered cAMP signal transduction.

Authors:  L E Nagy; I Diamond; A Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 2.  Ethanol and opioid receptor signalling.

Authors:  M E Charness
Journal:  Experientia       Date:  1989-05-15

3.  Acute ethanol intoxication may not alter alpha 2-adrenoceptors in the human brain.

Authors:  J J Meana; A M Gabilondo; F Barturen; J A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Functional analysis of T-cell subsets in chronic experimental alcoholism.

Authors:  O Bagasra; A Howeedy; R Dorio; A Kajdacsy-Balla
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.